Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Delaughter

Clinical Cardiac Electrophysiology Bedford, TX Medical Doctor

NPI 1528242336 CMS profile 295661

1305 Airport Fwy, Suite 301, Bedford, TX 76021

Open in the dashboard

General payments

$1,589,340

2,004 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$486,527 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Michael Delaughter of Bedford, TX is reported in the CMS Open Payments database as having received $1,589,340 across 2,004 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $486,527 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $220,604 213
2024 General $137,793 120
2023 General $416,987 422
2022 General $613,572 739
2021 General $21,591 135
2020 General $61,336 128
2019 General $117,459 247

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Delaughter
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Michael Delaughter were reported at $220,604. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Michael Delaughter Clinical Cardiac Electrophysiology median Middle half National median
2019 $117,459 $2,361 $585–$8,260 $163
2020 $61,336 $993 $247–$4,351 $114
2021 $21,591 $1,185 $326–$4,739 $132
2022 $613,572 $2,073 $554–$6,789 $149
2023 $416,987 $2,568 $759–$8,159 $160
2024 $137,793 $2,557 $703–$7,403 $164
2025 $220,604 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $1,394,435 1,558 payments
  2. Biosense Webster, Inc. $57,825 84 payments
  3. Boston Scientific Corporation $39,796 183 payments
  4. E.R. Squibb & Sons, L.L.C. $31,603 56 payments
  5. Pfizer Inc. $28,309 38 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18,996 12 payments
  7. CardioFocus, Inc. $8,853 7 payments
  8. Medtronic Vascular, Inc. $5,791 33 payments
  9. Medtronic, Inc. $2,357 5 payments
  10. Cardiva Medical, Inc. $328 3 payments
  11. Other $1,049 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $882,117 275 payments
  2. Travel and Lodging $551,314 958 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $98,969 30 payments
  4. Food and Beverage $46,134 732 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $10,275 3 payments
  6. Honoraria $500 1 payment
  7. Education $31 5 payments
Products named General payments · program years 2019–2025
  1. AMPLATZER AMULET $1,007,861 1,030 payments
  2. AMPLATZER Structural Heart $296,771 330 payments
  3. AMPLATZER Structural Heart $43,472 59 payments
  4. ELIQUIS Cardiovascular $31,603 56 payments
  5. ELIQUIS Cardiovascular;Metabolic Disease $28,290 37 payments
  6. Carto 3 System $28,272 34 payments
  7. LifeVest $18,996 12 payments
  8. Lasso $12,004 1 payment
  9. Thermocool $8,376 4 payments
  10. AMPLATZER Structural Heart $7,795 3 payments
  11. Other $92,979 402 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

2,004 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record